Market Overview

Karyopharm Therapeutics (NASDAQ: KPTI)

15.06 -0.32 (-2.08%)

Analyst Ratings

DateResearch FirmActionCurrentPT
1/17/20WedbushDowngradesNeutral
1/14/20H.C. WainwrightReiteratesBuy37.0
11/05/19Canaccord GenuityMaintainsBuy18.0
11/05/19H.C. WainwrightMaintainsBuy36.0
7/23/19JP MorganUpgradesOverweight16.0
3/01/19JP MorganDowngradesNeutral7.0
2/27/19WedbushMaintainsOutperform6.0
2/27/19Bank of AmericaDowngradesUnderperform
1/03/19Bank of AmericaUpgradesNeutral
11/09/18WedbushUpgradesOutperform

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter